Form 4: Century Therapeutics Exec Sells Shares for Tax Obligations

Douglas Carr, SVP Finance & Operations at Century Therapeutics, sold 292 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Douglas Carr, SVP Finance & Operations at Century Therapeutics, Inc. (IPSC), reported a sale of common stock.
• The transaction involved 292 shares of common stock.
• The shares were sold at a price of $0.586 per share.
• The sale occurred on November 3, 2025.
• The purpose of the sale was to cover tax withholding obligations associated with the vesting of restricted stock units.
• This sale was automatic and not at the discretion of Mr. Carr.
• Following the transaction, Mr. Carr beneficially owns 405,131 shares of common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale for tax purposes, which is neutral in terms of sentiment. It does not reflect a positive or negative view on the company's future by the insider.

Future Outlook

N/A

Management Comments

• The sales reported represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
• Such sales were automatic and not at the discretion of the Reporting Person.

Industry Context

Form 4 filings are standard disclosures for insider transactions, providing transparency into changes in beneficial ownership by company officers, directors, and significant shareholders. Sales for tax withholding purposes, as seen here, are common and typically not indicative of a change in management's outlook on the company's prospects, distinguishing them from discretionary sales.

Comparison to Industry Standards

• N/A This filing reports a routine insider transaction for tax purposes and does not contain performance data for comparison.

Stakeholder Impact

• Shareholders: Minimal impact, as the sale is small and non-discretionary, not signaling a change in insider confidence.
• Employees: No direct impact mentioned.
• Customers/Suppliers/Creditors: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary sale of a small number of shares by an executive to cover tax obligations related to restricted stock unit vesting. Such transactions are common and do not typically reflect a change in the insider's view of the company's fundamentals or future prospects. Therefore, it provides no new information that would warrant a change in investment thesis, and a 'hold' recommendation is appropriate.

Keywords

Century Therapeutics, IPSC, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Douglas Carr, Restricted Stock Units